Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Authors
  5. Dejan Radeski

Dejan Radeski

1PUBLICATIONS
17CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Nov 12, 2024
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas.

Won Seog Kim, Jake Shortt, Pier Luigi Zinzani

Pageof 1

Frequent Collaborators

1 joint publications

Won Seog Kim

1 joint publications

Jake Shortt

1 joint publications

Pier Luigi Zinzani

1 joint publications

Natalia Mikhailova

1 joint publications

Vincent Ribrag

1 joint publications

Eva Domingo Domenech

1 joint publications

Ahmed Sawas

1 joint publications

Karenza Alexis

1 joint publications

Michael Emig

1 joint publications

Riham Elbadri

Frequent Collaborators

1 joint publications

Won Seog Kim

1 joint publications

Jake Shortt

1 joint publications

Pier Luigi Zinzani

1 joint publications

Natalia Mikhailova

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

53.2K
See more related videos

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

53.2K
See more related videos